Zini Tommaso, Miselli Francesca, D'Esposito Chiara, Fidanza Lucia, Cuoghi Costantini Riccardo, Corso Lucia, Mazzotti Sofia, Rossi Cecilia, Spaggiari Eugenio, Rossi Katia, Lugli Licia, Bedetti Luca, Berardi Alberto
Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, 41125 Modena, Italy.
PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Trop Med Infect Dis. 2024 Mar 7;9(3):59. doi: 10.3390/tropicalmed9030059.
There are wide variations in antibiotic use in neonatal intensive care units (NICUs). Limited data are available on antimicrobial stewardship (AS) programs and long-term maintenance of AS interventions in preterm very-low-birth-weight (VLBW) infants.
We extended a single-centre observational study carried out in an Italian NICU. Three periods were compared: I. "baseline" (2011-2012), II. "intervention" (2016-2017), and III. "maintenance" (2020-2021). Intensive training of medical and nursing staff on AS occurred between periods I and II. AS protocols and algorithms were maintained and implemented between periods II and III.
There were 111, 119, and 100 VLBW infants in periods I, II, and III, respectively. In the "intervention period", there was a reduction in antibiotic use, reported as days of antibiotic therapy per 1000 patient days (215 vs. 302, < 0.01). In the "maintenance period", the number of culture-proven sepsis increased. Nevertheless, antibiotic exposure of uninfected VLBW infants was lower, while no sepsis-related deaths occurred. Our restriction was mostly directed at shortening antibiotic regimens with a policy of 48 h rule-out sepsis (median days of early empiric antibiotics: 6 vs. 3 vs. 2 in periods I, II, and III, respectively, < 0.001). Moreover, antibiotics administered for so-called culture-negative sepsis were reduced (22% vs. 11% vs. 6%, = 0.002), especially in infants with a birth weight between 1000 and 1499 g.
AS is feasible in preterm VLBW infants, and antibiotic use can be safely reduced. AS interventions, namely, the shortening of antibiotic courses in uninfected infants, can be sustained over time with periodic clinical audits and daily discussion of antimicrobial therapies among staff members.
新生儿重症监护病房(NICU)的抗生素使用存在很大差异。关于抗菌药物管理(AS)计划以及对早产极低出生体重(VLBW)婴儿进行AS干预的长期维持,现有数据有限。
我们扩展了在一家意大利NICU进行的单中心观察性研究。比较了三个时期:I. “基线期”(2011 - 2012年),II. “干预期”(2016 - 2017年),以及III. “维持期”(2020 - 2021年)。在I期和II期之间对医护人员进行了关于AS的强化培训。在II期和III期之间维持并实施了AS方案和算法。
I期、II期和III期分别有111例、119例和100例VLBW婴儿。在“干预期”,抗生素使用减少,以每1000患者日的抗生素治疗天数表示(215天对302天,<0.01)。在“维持期”,经培养证实的败血症病例数增加。然而,未感染的VLBW婴儿的抗生素暴露较低,且未发生与败血症相关的死亡。我们的限制主要针对缩短抗生素疗程,采用48小时排除败血症的政策(I期、II期和III期早期经验性抗生素的中位天数分别为6天、3天和2天,<0.001)。此外,用于所谓培养阴性败血症的抗生素减少(22%对11%对6%,=0.002),尤其是出生体重在1000至1499克之间的婴儿。
AS在早产VLBW婴儿中是可行的,并且可以安全地减少抗生素使用。AS干预措施,即缩短未感染婴儿的抗生素疗程,可以通过定期临床审核以及工作人员之间对抗菌治疗的日常讨论长期维持。